Immunological response to stress in agoraphobia and panic attacks.
The authors studied in vitro immune function as measured by lymphocytic proliferative response to mitogen stimulation in 36 patients with agoraphobia and panic attacks who were participating in a double-blind placebo-controlled psychopharmacological study of anxiety disorder. No significant difference in immune status was observed between panic patients and healthy controls.
D000328:Adult; D000379:Agoraphobia / Q000150:complications / Q000276:immunology*; D000525:Alprazolam; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D001569:Benzodiazepines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005239:Fear / Q000502:physiology*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008875:Middle Aged; D010200:Panic / Q000502:physiology*; D010624:Phenelzine / Q000627:therapeutic use; D010698:Phobic Disorders / Q000276:immunology*
D001569:Benzodiazepines; D010624:Phenelzine; D007099:Imipramine; D000525:Alprazolam